353 related articles for article (PubMed ID: 16650337)
1. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
[TBL] [Abstract][Full Text] [Related]
2. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
McConville M; Brennan GP; Flanagan A; Edgar HW; McCoy M; Castillo R; Hernández-Campos A; Fairweather I
Vet Parasitol; 2008 May; 153(1-2):52-64. PubMed ID: 18359570
[TBL] [Abstract][Full Text] [Related]
3. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
Parasitol Res; 2007 Jan; 100(2):365-77. PubMed ID: 17016729
[TBL] [Abstract][Full Text] [Related]
4. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
[TBL] [Abstract][Full Text] [Related]
5. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
Parasitol Res; 2011 Oct; 109(4):981-95. PubMed ID: 21442257
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
[TBL] [Abstract][Full Text] [Related]
8. Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
Parasitology; 2011 Feb; 138(2):224-36. PubMed ID: 20946692
[TBL] [Abstract][Full Text] [Related]
9. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
[TBL] [Abstract][Full Text] [Related]
10. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
[TBL] [Abstract][Full Text] [Related]
11. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha.
McConville M; Brennan GP; Flanagan A; Edgar HW; Castillo R; Hernández-Campos A; Fairweather I
Parasitology; 2009 May; 136(6):665-80. PubMed ID: 19368745
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
Parasitol Res; 2010 May; 106(6):1351-63. PubMed ID: 20336319
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
Vet Parasitol; 2012 Feb; 184(1):37-47. PubMed ID: 21872399
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
Vet Parasitol; 2011 May; 177(3-4):305-15. PubMed ID: 21208747
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
[TBL] [Abstract][Full Text] [Related]
18. Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica.
Halferty L; O'Neill JF; Brennan GP; Keiser J; Fairweather I
Parasitology; 2009 Sep; 136(11):1325-37. PubMed ID: 19660154
[TBL] [Abstract][Full Text] [Related]
19. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
Stitt AW; Fairweather I
Parasitol Res; 1993; 79(7):529-36. PubMed ID: 8278333
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica.
Meaney M; Haughey S; Brennan GP; Fairweather I
Parasitol Res; 2005 Feb; 95(3):201-12. PubMed ID: 15645289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
